Adoptive NK cell therapy in AML: progress and challenges.

Rady M, Mostafa M, Dida G, Sabet F, Abou-Aisha K, Watzl C

DOI: 10.1007/s10238-025-01559-5
Published: 2025 Jan 17
Container: Clinical and experimental medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10238-025-01559-5,
  title = {Adoptive NK cell therapy in AML: progress and challenges.},
  author = {Rady M and Mostafa M and Dida G and Sabet F and Abou-Aisha K and Watzl C},
  year = {2025},
  journal = {Clinical and experimental medicine},
  doi = {10.1007/s10238-025-01559-5},
  url = {https://doi.org/10.1007/s10238-025-01559-5}
}

RIS

TY  - JOUR
TI  - Adoptive NK cell therapy in AML: progress and challenges.
AU  - Rady M
AU  - Mostafa M
AU  - Dida G
AU  - Sabet F
AU  - Abou-Aisha K
AU  - Watzl C
PY  - 2025
JO  - Clinical and experimental medicine
DO  - 10.1007/s10238-025-01559-5
UR  - https://doi.org/10.1007/s10238-025-01559-5
ER  -

APA

M, R., M, M., G, D., F, S., K, A., & C, W. (2025). Adoptive NK cell therapy in AML: progress and challenges.. Clinical and experimental medicine. https://doi.org/10.1007/s10238-025-01559-5

Source records

pubmed · retrieved 2026-09-26T06:05:56.674Z